15.62°C Vancouver

Aug 19, 2025 4:25 PM - The Canadian Press

Health Canada approves Ozempic to reduce kidney deterioration in people with diabetes

Share On
health-canada-approves-ozempic-to-reduce-kidney-deterioration-in-people-with-diabetes
Between 30 and 50 per cent of people with Type 2 diabetes develop some form of chronic kidney disease."(Photo - The Canadian Press)

Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes.

Between 30 and 50 per cent of people with Type 2 diabetes develop some form of chronic kidney disease.

An international clinical trial, called FLOW, showed the risk of kidneys significantly deteriorating or failing was 24 per cent lower in patients taking Ozempic compared to those taking a placebo injection.

The patients taking the drug were also less likely to die from cardiovascular disease another condition that affects many patients with diabetes.

The study, funded by Ozempic manufacturer Novo Nordisk, was peer-reviewed and published in the New England Journal of Medicine last year and contributed to Health Canada's decision.

Dr. David Cherney, a nephrologist at Toronto General Hospital, helped lead the Canadian part of the trial and says the results show it's possible to reduce the loss of kidney function before patients need dialysis or a kidney transplant.

"What my patients are scared of is dialysis — dialysis or a transplant," said Cherney, who is also a senior scientist at the Toronto General Hospital Research Institute, in an interview.

"I can reasonably reduce that risk and thereby reduce their anxiety and fear of serious, serious complications. Not to mention all the cardiovascular disease, which patients are also extremely afraid of."

Dr. Ehud Ur, an endocrinologist in Vancouver who was not involved in the study, said the results are credible and that Health Canada's approval of Ozempic to help prevent kidney decline is "great news."

"The prevention of kidney disease is a very important goal in the management of patients with Type 2 diabetes and this is another tool," said Ur, who is a professor of endocrinology and metabolism at the University of British Columbia.

Ozempic is the brand name of an injectable dose of semaglutide, a glucagon-like peptide-1 (GLP-1) hormone. Ozempic was first approved in Canada as a diabetes medication because it reduces blood sugar. It can also decrease appetite and has been approved as a weight-loss drug for people with obesity at a higher dose under the brand name Wegovy, which is also manufactured by Novo Nordisk.

In an email, Health Canada confirmed to The Canadian Press that on Aug. 13, it had approved Ozempic "to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease and cardiovascular death in adults with Type 2 diabetes and chronic kidney disease."

Glomerular filtration rate is a measure that shows how well the kidneys are filtering out waste and excess water.

Ozempic is the firstGLP-1 drug approved in Canada to protect both kidneys and the heart in patients with Type 2 diabetes, said Ur, noting that the cardiovascular benefits of semaglutide have been extensively studied.

"The benefit of Ozempic is that you also get weight loss, which is a very important goal for most people (with Type 2 diabetes). That's a very exciting combination," he said.

Some people experience gastrointestinal side effects when they take Ozempic, Ur said, including nausea, vomiting, constipation and diarrhea.

More severe complications can include gall bladder inflammation and pancreatitis, but most side effects are minor, he said.

The benefit of slowing or stopping progressive kidney disease in people with diabetes would outweigh the risks of minor side effects, Ur said.

The FLOW trial was conducted in 28 countries, including Canada. The researchers randomized 3,533 people with diabetes and chronic kidney disease to either receive Ozempic or a placebo. The study was conducted between 2019 and early 2024.

Participants were followed for an average of 3.4 years to monitor for "major kidney disease events," including kidney failure leading to dialysis or transplantation, a 50-per-cent reduction in kidney function measured by glomerular filtration rate, or death from kidney-related or cardiovascular causes.

The Ozempic or placebo doses were given to participants on top of other medications they were taking, including drugs to control blood pressure and blood sugar.

Although reducing blood pressure and blood sugar have beneficial effects for the kidneys, Cherney said Ozempic appeared to have an additional positive impact on kidney function and future research can help pinpoint how that works.

"Another weapon against kidney disease is incredibly powerful. And these medicines will often turn patients around who are doing very poorly because it addresses so many different issues — the kidney, the cardiovascular, the metabolic, and the weight," said Cherney.

Ur said it's possible Ozempic could play a role in reducing inflammation in the kidneys and that might be one explanation for its positive effect.

Regardless of the reason for its effectiveness, he said the FLOW trial and Health Canada's approval reinforces the importance of using the drug "relatively early in the disease process" to minimize kidney damage in people with Type 2 diabetes.


Latest news

almost-half-of-canadians-want-the-temporary-foreign-worker-program-eliminated-poll
CanadaSep 08, 2025

Almost half of Canadians want the Temporary Foreign Worker program eliminated: poll

A new poll suggests 44 per cent of Canadians want to see the temporary foreign worker program scrapped as the country grapples with high unemployment, especially among young people. Conservative Leader Pierre Poilievre recently proposed eliminating the program in response to high youth unemployment. The new Abacus Data poll, which was conducted online and can't be assigned a margin of error, suggests that support for eliminating the program is higher among younger age cohorts, topping 50 per cent of 30- to 44-year-old respondents and hitting 48 per cent of those 18 to 29. Support for ending th
union-to-announce-next-phase-of-b-c-public-service-strike
BCSep 08, 2025

Union to announce next phase of B.C. public service strike

The president of the B.C. General Employees’ Union is set to make an announcement this morning laying out the next phase of the union's public service strike. The union says Paul Finch is scheduled to speak at a picket line in Surrey on the fifth consecutive day of picketing following the launch of job action last Tuesday. The union represents more than 34,000 members working for B.C.'s public service and has held picket lines at locations including government sites in Victoria, Surrey, and Prince George, and the Royal BC Museum. It says some of its key asks include competitive wages and fai
radio-connect-fm-canada-extends-a-helping-hand-to-the-flood-victims-of-punjab
CanadaSep 08, 2025

Radio Connect FM Canada extends a helping hand to the flood victims of Punjab

Connect FM Radio has decided to run a special donation and fundraising campaign on Monday, September 8, as a special initiative to help the flood affected families of Punjab. This program is being run in collaboration with Guru Nanak Food Bank Gurdwara Dukh Niwaran Sahib Surrey and Sanjha TV. The funds collected under this program will be delivered to Punjab through capable hands to the flood affected families so that their lives can be brought back on track. This program is expected to receive great support from all Canadians and especially the Punjabi community.
canadas-dabrowski-and-partner-routliffe-win-u-s-open-womens-doubles-title
EnglishSep 05, 2025

Canada's Dabrowski and partner Routliffe win U.S. Open women's doubles title

Canadian tennis player Gabriela Dabrowski has won the US Open Grand Slam title with her New Zealand partner Erin Rutliff. The Canadian player won the women's doubles title in straight sets with her partner. Together, the two defeated the pair of Taylor Townsend and Katerina Siniakova 6-4, 6-4. Earlier, Gabriela Dabrowski also won the US Open title in 2023. Pawan Sahni, of Newton Tennis Club in Surrey, says “the win is a boost for Canadian tennis.” He added, on one hand, just a few weeks ago, young player Victoria Mboko won the Canadian Open title, and now, with Canada's senior player win
BCSep 05, 2025

Coquihalla Highway reopened following wildfire closure

The Coquihalla Highway (Highway 5) between Hope and Merritt has reopened in both directions following a closure caused by the Mine Creek wildfire. Due to the proximity of the fire, drivers should be prepared for the Coquihalla Highway to be closed with minimal notice. Drivers are advised to not stop in the fire zone. Intermittent lane closures can be expected as crews continue to assess and repair roadside damage, and visibility is reduced due to wildfire smoke. Drivers should also be prepared for an increased risk of wildlife presence due to fire damage to wildlife-exclusion fencing on this s

Related News